Vanda Pharmaceuticals | VNDA - Dividend Yield


Vanda Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Anika Therapeutics 0 0 Mar/2025
AstraZeneca USD 1.75 0.57 Jun/2026
Bristol-Myers Squibb 4.36 0.23 Jun/2026
Eli Lilly 0.56 0.02 Jun/2026
Enanta Pharmaceuticals 0 0 Mar/2025
Heron Therapeutics 0 0 Mar/2025
J&J 1.95 0.11 Sep/2026
Lexicon Pharmaceuticals 0 0 Mar/2025
Merck 2.62 0.14 Jun/2026
Minerva Neurosciences 0 0 Mar/2025
Novartis 3.1 0.21 Mar/2026
Pfizer 7.08 0.72 Jun/2026
Puma Biotechnology 0 0 Mar/2025
Sangamo BioSciences 0 0 Mar/2025
Sanofi 5.49 0.51 Jun/2026
Takeda 3.88 2.23 Jun/2026
Vanda Pharmaceuticals 0 0 Mar/2025